Constar says it now holds regulatory access in eight contact lens markets

Gansu Constar Technology Group says it has assembled FDA, CE and ISO credentials plus registrations in Australia, Saudi Arabia, Indonesia, Thailand and Vietnam, giving distributors one manufacturer for multiple regulated markets. The company says the portfolio is meant to cut duplicate sourcing, packaging and audit work as contact lenses face tighter medical-device oversight.

Why it matters: - Gansu Constar Technology Group says the expanded portfolio lets brand owners and distributors source contact lenses from one manufacturer across eight regulated markets. - The company says that can reduce the need to split production, packaging and quality audits across multiple factories. - The shift matters as more countries treat contact lenses as medical devices rather than consumer cosmetic products.

What happened: - Gansu Constar Technology Group said on September 23, 2026, that it holds registrations across eight regulated contact lens markets. - The portfolio combines FDA 510(k) clearance, CE 0197 marking and ISO 13485 certification with five national market authorisations. - The five national registrations are Australia’s TGA ARTG listing, Saudi Arabia’s SFDA license, Indonesia’s AKL Kemenkes permit, Thailand’s TFDA license and Vietnam’s Class B registration. - The company also holds China NMPA medical device manufacturing and business licences.

The details: - US FDA 510(k) clearance covers Constar’s soft contact lens range, including daily disposable, monthly and coloured cosmetic designs. - CE marking under EU Medical Device Regulation 2017/745 is required to place contact lenses on the European Economic Area market. - The CE 0197 designation identifies the notified body that reviewed the manufacturer’s conformity. - ISO 13485 is the medical-device quality management standard used as a baseline in many national registration processes. - Australia’s TGA ARTG listing dates to 2024. - Saudi Arabia’s SFDA license dates to 2024. - Indonesia’s AKL Kemenkes permit dates to 2024. - Thailand’s TFDA license dates to 2023. - Vietnam’s Class B registration dates to 2024. - The company says every export shipment includes destination-specific documentation such as HS codes, Certificates of Compliance, batch quality reports and the relevant regulatory filings. - Constar manufactures across six production facilities in Gansu and Hunan provinces. - The company says combined output reaches 15 million lenses per month. - Constar says it supplies distributors and brand owners in more than 40 countries.

Between the lines: - Regulatory breadth is becoming a competitive advantage as contact lens oversight tightens in Southeast Asia and the Middle East. - A single manufacturer with multiple registrations can simplify cross-border distribution for brands selling in the US, Europe and several regional markets. - The portfolio also signals that compliance infrastructure can be as important as product design in winning international accounts.

What's next: - The company is positioning the portfolio to help brand owners enter new markets without changing suppliers. - Constar says its market coverage is detailed on its website. - More registrations would further expand the company’s addressable export footprint if additional markets are added later.

The bottom line: - Constar is using regulatory coverage, not just manufacturing capacity, as the core selling point for global contact lens supply.